CLPTM1L Antibody

Product Specs
ItemCLPTM1L Antibody - BSA Free
CompanyNovus Biologicals, a Bio-Techne Brand
Price $389.00Supplier Page View Company Product Page
Catalog NumberNBP1-62477
Quantity100 ul
ImmunogenSynthetic peptides corresponding to CLPTM1L(CLPTM1-like) The peptide sequence was selected from the middle region of CLPTM1L (NP_110409). Peptide sequence KAFTYKAFNT FIDDVFAFII TMPTSHRLAC FRDDVVFLVY LYQRWLYPVD. The peptide sequence for this immunogen was taken from within the described region
NCBI Gene AliasesCRR9
HostRabbit
ReactivityHuman
TargetCLPTM1L
Conjugate/TagUnconjugated
ApplicationsIF/IHC,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin
FormatPBS, 2% Sucrose
NCBI Full Gene NameCLPTM1 like
ClonalityPolyclonal
PurityAffinity purified
Molecular Weight62 kDa
IsotypeIgG
Antibody TypePrimary Antibodies
Research AreaApoptosis, Cell Biology
StorageStore at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles
Concentration0.5 mg/ml

Specifications/Features

Available conjugates: Available conjugates: Unconjugated

Sizes Available: 100 ul

Add to Compare List

Novus Biologicals, a Bio-Techne Brand

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

Company Profile

Website: https://www.novusbio.com

(1) Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistanceNPJ precision oncologyMarch 2, 2021Parashar D, Geethadevi A, McAllister D, Ebben J, Peterson FC, Jensen DR, Bishop E, Pradeep S, Volkman BF, Dwinell MB, et al.(Human: Polyclonal anti-CLPTM1L (HPA014791, Sigma Aldrich, St. Louis, MO, Mouse: Novus anti-CLPTM1L, NBP1-62477) was performed on the Dako Autostainer Plus using the Dako EnVision™ FLEX High pH Detection Kit (K8010)

(2) CLPTM1L/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cellsInternational journal of cancerMarch 15, 2019Clarke WR, Amundadottir L, James MA.

Be the First to Write a Review!